Anja Feldmann

Dresden, SN 01307, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Preclinical evaluation of homodimeric FAPI target modules for UniCAR-mediated targeting of FAP-expressing tumor and stromal cells.

Preclinical evaluation of homodimeric FAPI target modules for UniCAR-mediated targeting of FAP-expressing tumor and stromal cells.

Journal: Oncoimmunology

Published: August 21, 2026

The Evolution of FAP-Targeted CAR T-Cell Therapy in Solid Tumors: From Immunotherapy to Immunotheranostic Applications.

The Evolution of FAP-Targeted CAR T-Cell Therapy in Solid Tumors: From Immunotherapy to Immunotheranostic Applications.

Journal: International journal of molecular sciences

Published: July 01, 2026

Novel PSCA-Targeting Adapter Molecules for Late-Stage RevCAR-T Cell Therapy in Prostate Cancer.

Novel PSCA-Targeting Adapter Molecules for Late-Stage RevCAR-T Cell Therapy in Prostate Cancer.

Journal: International journal of molecular sciences

Published: June 03, 2026

Novel immunotheranostic FAP-inhibitor target modules for imaging and elimination of FAP-positive cells by UniCAR T-cells.

Novel immunotheranostic FAP-inhibitor target modules for imaging and elimination of FAP-positive cells by UniCAR T-cells.

Journal: Oncoimmunology

Published: December 15, 2025

Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity.

Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 12, 2025

Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity.

Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 12, 2025

Epigenetic editing balances TCR suppression and persistence in CAR T cells.

Epigenetic editing balances TCR suppression and persistence in CAR T cells.

Journal: Molecular therapy. Advances

Published: September 03, 2025

Automated GMP-compatible production of universal CAR Tregs for organ-targeted tolerance induction.

Automated GMP-compatible production of universal CAR Tregs for organ-targeted tolerance induction.

Journal: Journal of translational medicine

Published: August 18, 2025

Microphysiological Solid Tumor Models in Hydrogel Beads for CAR T Cell Immunotherapy Evaluation.

Microphysiological Solid Tumor Models in Hydrogel Beads for CAR T Cell Immunotherapy Evaluation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 12, 2025

CliniMACS Prodigy Manufacturing of Switchable, AND-Gate CAR T Cells.

CliniMACS Prodigy Manufacturing of Switchable, AND-Gate CAR T Cells.

Journal: International journal of molecular sciences

Published: April 30, 2025

Exploring Morphology of Thermoplasmonic Nanoparticles to Synergize Immunotherapeutic Fibroblast Activation Protein-Positive Cell Sensitization and Photothermal Therapy.

Exploring Morphology of Thermoplasmonic Nanoparticles to Synergize Immunotherapeutic Fibroblast Activation Protein-Positive Cell Sensitization and Photothermal Therapy.

Journal: Small science

Published: February 14, 2025

Tackling Prostate Cancer with Theranostic E5B9-Bombesin Target Modules (TMs): From Imaging to Treatment with UniCAR T-Cells.

Tackling Prostate Cancer with Theranostic E5B9-Bombesin Target Modules (TMs): From Imaging to Treatment with UniCAR T-Cells.

Journal: International journal of molecular sciences

Published: February 06, 2025

Showing 1-12 of 87

Last Updated: 09/26/2026